CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹41,595 Cr | ₹36,742 Cr | ₹32,130 Cr | ₹29,007 Cr | ₹26,652 Cr |
What is the latest Total Assets ratio of CIPLA ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹41,595 Cr |
| Mar2025 | ₹36,742 Cr |
| Mar2024 | ₹32,130 Cr |
| Mar2023 | ₹29,007 Cr |
| Mar2022 | ₹26,652 Cr |
How is Total Assets of CIPLA Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹41,595 Cr | 13.21 | |
| Mar2025 | ₹36,742 Cr | 14.35 | |
| Mar2024 | ₹32,130 Cr | 10.77 | |
| Mar2023 | ₹29,007 Cr | 8.83 | |
| Mar2022 | ₹26,652 Cr | - | |
Compare Total Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹109,874.4 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,584.0 Cr | 9.1% | 0.3% | 2.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2.3% |
-2.7% |
-18.9% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses